Showing results (111-120 of 157) with videos related to
Sort By:
Pageof 16
Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.Communications Chemistry|January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in micePascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.Bioorganic & Medicinal Chemistry|April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.ACS Medicinal Chemistry Letters|April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 AgonistsAlisa Lang, Niklas Ildefeld, Felix F Lillich, et al.Journal of Medicinal Chemistry|June 11, 2021
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma CellsGiuseppe Faudone, Iris Bischoff-Kont, Lea Rachor, et al.Journal of Medicinal Chemistry|April 1, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and PharmacokineticsSimone Schierle, Apirat Chaikuad, Felix F Lillich, et al.Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.Journal of Medicinal Chemistry|January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical PropertiesMax Lewandowski, Melania Carmina, Loris Knümann, et al.ACS Pharmacology & Translational Science|December 20, 2021
The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to XanthinesGiuseppe Faudone, Whitney Kilu, Xiaomin Ni, et al.Chemmedchem|November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from ZafirlukastSimone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.Pageof 16